RxDoctor Payments Data

Rodrine Buffaloe, MD

Family Medicine · Ware Shoals, SCNPI 1700171584

Payments from drug & device makers

$4,640in general payments, 2019–2025

Across 270 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$584
  • Lilly USA, LLC$554
  • Novo Nordisk$483
  • Merck$432
  • AbbVie$349
  • GSK$321
  • plus $2K from 20 others

What the payments were for

  • Food & beverage$4,640100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,640 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$115,949
Medicare patients
184
Services billed
2,021

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide209$238,503
EliquisApixaban135$126,346
XifaxanRifaximin20$75,387
JardianceEmpagliflozin58$70,553
JanuviaSitagliptin Phosphate59$65,230
OzempicSemaglutide43$54,053
FarxigaDapagliflozin Propanediol42$49,336
LinzessLinaclotide44$47,935
MyrbetriqMirabegron48$44,748
RybelsusSemaglutide30$43,557
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$32,661
XareltoRivaroxaban32$30,709
EntrestoSacubitril/Valsartan21$25,951
TrulicityDulaglutide29$24,347
Breztri AerosphereBudesonide/Glycopyr/Formoterol28$23,944

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$554$262,850238 claims
PfizerEliquis$222$126,346135 claims
Novo NordiskOzempic, Rybelsus$483$97,60973 claims
MerckJanuvia, Janumet Xr$432$88,92577 claims
Boehringer IngelheimJardiance, Tradjenta$203$85,33870 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$584$79,71194 claims
GSKTrelegy Ellipta, Breo Ellipta$321$50,29366 claims
AbbVieLinzess$349$47,93544 claims
Astellas Pharma US IncMyrbetriq$271$44,74848 claims
NovartisEntresto$134$25,95121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Ware Shoals

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →